| 000 | 01772 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515230611.0 | ||
| 264 | 0 | _c20110526 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1573-4978 | ||
| 024 | 7 |
_a10.1007/s11033-010-0236-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerreros-Villanueva, Marta | |
| 245 | 0 | 0 |
_aPIK3CA mutations in KRAS and BRAF wild type colorectal cancer patients. A study of Spanish population. _h[electronic resource] |
| 260 |
_bMolecular biology reports _cFeb 2011 |
||
| 300 |
_a1347-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 | _aClass I Phosphatidylinositol 3-Kinases |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xethnology |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Proteins p21(ras) |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_aras Proteins _xgenetics |
| 700 | 1 | _aGomez-Manero, Noemí | |
| 700 | 1 | _aMuñiz, Pilar | |
| 700 | 1 | _aGarcía-Girón, Carlos | |
| 700 | 1 | _aComa del Corral, Maria Jesús | |
| 773 | 0 |
_tMolecular biology reports _gvol. 38 _gno. 2 _gp. 1347-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11033-010-0236-6 _zAvailable from publisher's website |
| 999 |
_c19920276 _d19920276 |
||